Stock Markets Analysis & Opinion

Wednesday July 19, 2017The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including IBM (IBM),...

Huge profits and earnings surprises can lure you this earnings season. But rather than accumulating stocks later, investing in those that are yet to release their numbers and poised to beat...

Social media giant Facebook Inc. (NASDAQ:FB) recently confirmed that it is launching a news subscription feature that will give publishers the option to lock Instant Articles behind a...

Nektar Therapeutics (NASDAQ:NKTR) shares increased more than 4% on Tuesday after the company announced positive top line results from an oral human abuse potential (HAP) study, evaluating its opioid...

The past week saw Atlanta, GA-based Delta Air Lines (NYSE:DAL) kick-start the second-quarter earnings season for the airline space. The carrier reported lower-than-expected earnings and revenues...

We have already seen a few releases from S&P 500 companies in the Q2 earnings season. Major oilfield services companies will start reporting results starting Jul 21. Although our report shows that...

The U.S. equity markets were mixed, as continued pressure on Treasury yields and a disappointing report from Goldman Sachs pressured financials, but a blowout quarter from Netflix gave consumer...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) and BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) , have settled their ongoing global patent litigation regarding the exclusive license on a patent pertaining...

The defense stocks in the U.S. got a solid boost due to the U.S. House of Representatives passing the 2018 defense policy bill last Friday. The bill, reflecting a spending level of $696 billion,...

Technology industry giants—including Apple (NASDAQ:AAPL) , Facebook (NASDAQ:FB) , and Microsoft (NASDAQ:MSFT) —have helped send both the Nasdaq and S&P 500 to record highs during...

Abzena PLC (LON:ABZA) has announced another licensing deal, this time involving its Composite Human Antibody technology. The deal is with Telix Pharmaceuticals, a biopharmaceutical company which...

"The four most dangerous words in investing are: 'this time it's different.'" - Sir John TempletonThe above quote pretty much defines the nature of the stock market. Well, the Retail – Wholesale...

In the midst of Q2 earnings season, Illinois Tool Works (NYSE:ITW) prepares to release its second-quarter 2017 report on July 24. Illinois Tool Works manufactures and markets a variety of products...

Donegal Group Inc. (NASDAQ:DGICA) (NASDAQ:DGICB) has estimated a catastrophe loss of about $20.1 million in the second quarter of 2017. The insurer projects to incur loss between 7 and 9 cents per...